Cresset Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Cresset Asset Management's BIIB Position: Q2 2026 in Review
Cresset Asset Management reduced its Biogen (BIIB) stake by 9.3% in Q2 2026, selling an estimated $1.19M and leaving 61,258 shares worth $13.2M. The position accounts for 0.05% of the portfolio, ranked #233.
Cresset Asset Management first reported a position in BIIB in Q4 2018 and has held it in 30 quarters since. The position peaked at $13.4M in Q4 2025. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Cresset Asset Management held 61,258 shares of Biogen worth $13.2M as of Q2 2026.
- Cresset Asset Management sold 6,245 Biogen shares in Q2 2026, an estimated $1.19M.
- Biogen made up 0.05% of Cresset Asset Management's portfolio in Q2 2026, its #233 holding.
- Cresset Asset Management first reported a position in Biogen in Q4 2018 and has held it in 30 quarters since.
- Cresset Asset Management's Biogen position peaked at $13.4M in Q4 2025.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.